北京大学肿瘤医院 主任医师
擅长: 肺癌和食管癌以放疗为主的综合治疗。
简介: 肿瘤学博士后,主任医师,国家自然科学基金评委。1998年中国医科大学本科毕业后主要从事肿瘤的临床工作,擅长肺癌和食管癌以放疗为主的综合治疗。外语基础较好,善于学习本专业前沿知识,掌握肿瘤治疗的最新信息和方法。作为负责人主持国家自然科学基金面上项目2项,中国博士后基金特别资助、中国博士后基金一等资助各1项,在国内外专业杂志发表论文40余篇,其中SCI收录15篇,被引用90余次。申请国家专利1项,获省级奖励2项。发表论文:1. Liu Y, Zhu G, Han L, Liu J, Ma T, Yu HM*(通讯作者). Clinical study on the prevention of oxaliplatin-induced neurotoxicity with guilongtongluofang: results of a randomized, double-blind, placebo-controlled trial. Evidence-Based Complementary and Alternative Medicine. 2013;2013:541217. doi: 10.1155/2013/541217.2. Liu YF, Xia TY, Zhang WJ, Zhong YJ, Zhang LH, Wang X, Yu HM*(通讯作者). Variations of circulating endothelial progenitor cells and transforming growth factor-beta-1 (TGF-beta1) during thoracic radiotherapy are predictive for radiation pneumonitis. Radiation Oncology 2013;8(1):189-1973. Yu HM, Zhu GY. Major radiation oncology advances 2012 in China. Austral-Asian Journal of Cancer 2013;12(2):63-674. Liu YF#, Yu HM# (共同第一), Zhang C, Cheng Y, Hu L, Meng X, Zhao Y. Protective effects of berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancer. European Journal of Cancer 2008;44(16):2425-24325. Yu HM, Liu YF, Yu JM, Liu J, Zhao Y, Hou M. Involved-field radiotherapy is effective for patients 70 years old or more with early stage non-small cell lung cancer. Radiotherapy and Oncology 2008;87(1):29-346. Yu HM, Liu YF, Cheng YF, Hu LK, Hou M. Effects of rhubarb extract on radiation induced lung toxicity via decreasing transforming growth factor-beta-1 and interleukin-6 in lung cancer patients treated with radiotherapy. Lung Cancer 2008;59(2):219-2267. Yu HM#(共同第一), Liu YF#, Hou M, Liu J, Li XN, Yu JM. Evaluation of gross tumor size using CT, (18)F-FDG PET, integrated (18)F-FDG PET/CT and pathological analysis in non-small cell lung cancer. European Journal of Radiology 2009;72(1):104-1138. Yu HM#(共同第一), Liu YF#, Han JQ, Yang Z, Sheng W, Dai HH, Wang YJ, Xia TY, Hou M. TLR7 regulates dendritic cell-dependent B-cell responses through BlyS in immune thrombocytopenic purpura. European Journal of Haematology 2010; 86(12):67–749. Yu HM, Liu YF, Hou M. BAFF – an essential survival factor for B cells: Links to genesis of ITP and may be of therapeutic target. Medical Hypotheses 2008;70(1): 40-4210. Liu YF, Yu HM, Zhang C, Yang RX, Yan FF, Liu Y, Zhang Y, Zhao YX. Effect of Quyu Xiaoban capsules on clinical outcomes and platelet activation and aggregation in patients with unstable angina pectoris. Journal of Alternative and Complementary Medicine 2007;13(5): 571-57611. Liu YF, Yu HM, Zhang C, Yan FF, Liu Y, Zhang Y, Zhang M, Zhao YX. Treatment with rhubarb improves brachial artery endothelial function in patients with atherosclerosis: a randomized, double-blinded clinical trial. American Journal of Chinese Medicine 2007;35(4): 583-59512. Liu YF, Yu HM, Zhang Y, Zhao Y. TLRs are important inflammatory factors in atherosclerosis and may be a therapeutic target. Medical Hypotheses 2008; 70(2): 314-31613. Liu M, Sjogren AK, Karlsson C, Ibrahim MX, Andersson KM, Olofsson FJ, Wahlstrom AM, Dalin M, Yu HM, Chen Z, Yang SH, Young SG, Bergo MO. Targeting the protein prenyltransferases efficiently reduces tumor development in mice with K-RAS-induced lung cancer. Proceedings of the National Academy of Sciences of the United States of America 2010;107(14):6471-647614. Yang Q, Wang B, Yu HM, Zhu Y, Wang X, Jiang H, Wang C, Peng J, Hou M. TLR7 promotes Th1 polarization in immune thrombocytopenia. Thrombosis Research 2011;128(3): 237-24215. Sun C, Yu HM, Wang X, Han J. A pilot study of extremely low-frequency magnetic fields in advanced non-small cell lung cancer: Effects on survival and palliation of general symptoms. Oncology Letter 2012;4(5):1130-113416. Sun C, Sheng W, Yu HM, Han J.Giant cell tumor of the tendon sheath: A rare case in the left knee of a 15-year-old boy. Oncology Letter 2012;(3):718-72017. Wang C, Song B, Song W, Liu J, Sun A, Wu D, Yu HM, Lian J, Chen L, Han J. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients. Journal of Gastroenterology and Hepatology 2011;26(11):1630-163718. Liu YF, Yan F, Liu Y, Zhang C, Yu HM, Zhang Y, Zhao Y. Aqueous extract of rhubarb stabilizes vulnerable atherosclerotic plaques due to depression of inflammation and lipid accumulation. Phytotherapy Research 2008; 22(7):935- 94219. Liu YF, Zhao YX, Yu HM. Effects of Quyu xiaoban capsule on vascular endothelial function in patients with atherosclerosis. Chinese Journal of Integrative Medicine 2006;12(3): 171-17420. Zhao YX, Liu YF, Yu HM. Clinical study of acoustic densitometry technique in detecting atherosclerotic plaque. Chinese Journal of Integrative Medicine 2005;11(3):183-18621. 于会明, 刘运芳, 于金明. 三维适形放疗联合吉西他滨治疗局部晚期胰腺癌的疗效分析.中华放射肿瘤学杂志2006;15(1):56-5722. 于会明, 于金明, 刘运芳, 赵献光, 马丽. 氟脱氧葡萄糖正电子发射型体层摄影术在非小细胞肺癌适形放疗中的应用研究. 中华放射肿瘤学杂志2005;14(2): 105-10723. 于会明, 于金明, 范廷勇, 蔡淑平. 软组织非霍奇金B细胞型淋巴瘤一例. 中华肿瘤杂志 2003;25(6):595-595
第一执业
广东罗浮山国药股份有限公司是一家从事药品生产,药品经营,中草药收购等业务的公司,成立于2008年12月24日,公司坐落在广东省,详细地址为:惠州市博罗县长宁镇广汕公路边岭排工业区(罗浮山药业城);经国
北京韩美药品有限公司(以下简称北京韩美)成立于1996年3月,公司产品业务涉及儿科产品、消化科产品、骨科产品、抗感染药等领域,98%的产品在国内成产,主要产品有妈咪爱、易坦静、易安平、美常安、利动、
益普生集团作为一家有着八十多年制药经验的欧洲制药集团,拥有20余种上市产品及遍布全球近4000名的员工。公司的发展战略是以三大治疗领域内的高科技产品为基础,即肿瘤、内分泌、神经肌肉类疾病,这些高
北京同仁堂股份有限公司同仁堂制药厂成立于1990年11月21日,注册地位于北京市大兴区中关村科技园区大兴生物医药产业基地天贵大街33号,法定代表人为张朝华。经营范围包括加工、制造中成药;出租办公用房
辉瑞在中国业务覆盖全国300余个城市,并在华上市了五大领域的高品质的创新药物,包括肿瘤、疫苗、抗感染、炎症与免疫、罕见病等多个领域的处方药和疫苗。多年来,辉瑞始终致力于“成为中国医疗卫生体系重要组成
石家庄以岭药业股份有限公司于1992年6月16日创建,公司以“继承创新、造福人类”为企业宗旨,以“科技健康明天”为企业发展目标,以健康人类为己任,造福社会为弘愿,始终坚持市场龙头、科技驱动的创新发展
北京同仁堂科技发展股份有限公司制药厂成立于1980年07月31日,注册地位于北京市丰台区南三环中路20号,法定代表人为王煜炜。经营范围包括制造胶剂、口服液、丸剂、颗粒剂、糖浆剂、擦剂、气雾剂、软胶囊
海南碧凯药业有限公司成立于1993年。是【国家高新技术企业】、国家工商总局【守合同重信誉单位】、海口工业【十佳企业】。拥有各类人才,员工近2000人。生产基地位于海口药谷,占地134亩,建筑面积10